1. Dermatological toxicities of Bruton’s tyrosine kinase inhibitors;Sibaud;Am J Clin Dermatol,2020
2. Extensive ecchymotic patch in a patient with chronic lymphocytic leukemia;Guenther;Int J Dermatol,2024
3. A uniquely distributed purpuric drug eruption from acalabrutinib;Truong;Australas J Dermatol,2022
4. Case report: zanubrutinib-induced dermatological toxicities: a single-center experience and review;Wang;Front Oncol,2022
5. Imbruvica (Ibrutinib) induced subcutaneous hematoma: a case report;Jani;Curr Probl Cancer Case Rep,2021